Panbela Therapeutics: Advancing Disruptive Therapies for Pancreatic Diseases
Shares of Panbela Therapeutics, Inc. experienced a drop of 6.94%, closing at $0.3250. The company, however, remains at the forefront of innovative therapeutic development aimed at addressing critical medical needs. Pioneering Solutions for Pancreatic Diseases…